Role of oestrogen therapy in the management of short stature in Turner syndrome

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 88, Issue 433, 1999, Pages 130-132

  Chernausek, S D ^a   Attie, K M ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b GENENTECH INC   (United States)

Author keywords

Epiphyseal fusion; Growth hormone; Hypogonadism; Oestrogen; Turner syndrome

Indexed keywords

CONJUGATED ESTROGEN; GROWTH HORMONE;

ADOLESCENT; BODY HEIGHT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EPIPHYSIS PLATE; ESTROGEN THERAPY; FEMALE; GROWTH STIMULATION; HUMAN; HYPOGONADISM; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SHORT STATURE; TURNER SYNDROME;

AGE FACTORS; BODY HEIGHT; BONE AND BONES; ESTRADIOL CONGENERS; FEMALE; HUMAN GROWTH HORMONE; HUMANS; TREATMENT OUTCOME; TURNER SYNDROME;

EID: 0033410176     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. MacGillivray MH, Morishima A, Conte F, Grumbach M, Smith EP. Pediatric endocrinology update: an overview. The essential roles of estrogens in pubertal growth, epiphyseal fusion and bone turnover: lessons from mutations in the genes for aromatase and estrogen receptor. Horm Res 1998; 49(Suppl 1): 2-8
2. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994; 331: 1056-61
3. Simpson ER, Genetic mutations resulting in estrogen insufficiency in the male. Mol Cell Endocrinol 1998; 145: 55-9
4. Ross JL, Cassorla FG, Skerda MC, Valk IM, Loriaux DL, Cutler GB Jr. A preliminary study of the effect of estrogen dose on growth in Turner's syndrome. N Engl J Med 1983; 309: 1104-6
5. Ross JL, Long LM, Skerda M, Cassorla F, Kurtz D, Loriaux DL, et al. Effect of low doses of estradiol on 6-month growth rates and predicted height in patients with Turner syndrome. J Pediatr 1986; 109: 950-3
6. Rosenfeld RG, Attie KM, Frane J, Brasel JA, Burstein S, Cara JF, et al. Growth hormone therapy of Turner syndrome: beneficial effect on adult height. J Pediatr 1998; 132: 319-24
7. Rosenfield RL, Perovic N, Devine N, Mauras N, Moshang T, Root AW, et al. Optimizing estrogen replacement in Turner syndrome. Pediatrics 1998; 102: 486-8
8. Vanderschueren-Lodeweyckx M, Massa G, Maes M, Craen M, van Vliet G, Heinrichs C, et al. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome. J Clin Endocrinol Metab 1990; 70: 122-6
9. Job JC. How sex steroids can modify the effect of growth hormone on growth in Turner syndrome. In: Hibi I, Takano K, editors. Basic and clinical approach to Turner syndrome. Amsterdam: Elsevier Science Publishers BV, 1993; 279-85
10. Chernausek SD, Cara JF, Rosenfeld RG, Attie KM, Frane J. Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement upon final height. J Clin Endocrinol Metab 1999; (submitted)
11. Attanasio A, James D, Reinhardt R, Rekers-Mombarg L. Final height and long-term outcome after growth hormone therapy in Turner syndrome: results of a German multicentre trial. Horm Res 1995; 43: 147-9
12. Nilsson KO, Albertsson-Wikland K, Alm J, Aronson S, Gustafsson J, Hagenas L, et al. Improved final height in girls with Turner syndrome treated with growth hormone and oxandrolone. J Clin Endocrinol Metab 1996; 81: 635-40
13. Taback SP, Collu R, Deal CL, Guyda HJ, Salisbury S, Dean HJ, et al. Does growth-hormone supplementation affect adult height in Turner syndrome? Lancet 1996; 348: 25-7
14. Takano K, Shizume K, Hibi I, Ogawa M, Okada Y, Suwa S, et al. Long term effects of growth hormone treatment on height in Turner syndrome: results of a 6-year multicentre study in Japan. Committee for the treatment of Turner syndrome. Horm Res 1995; 43: 141-3
15. Van den Broeck J, Massa GG, Attanasio A, Matranga A, Chaussain J-L, Price DA, et al. Final height after long-term growth hormone treatment in Turner syndrome, J Pediatr 1995; 127: 729-35
16. Davies MC, Gulekli B, Jacobs HS. Osteoporosis in Turner's syndrome and other forms of primary amenorrhoea. Clin Endocrinol (Oxf) 1995; 43: 741-6
17. Sylven L, Hagenfeldt K, Ringertz H. Bone mineral density in middle-aged women with Turner's syndrome. Eur J Endocrinol 1995; 132: 47-52